AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 226 filers reported holding AMICUS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,506,855 | +592.6% | 123,919 | +615.4% | 0.00% | +300.0% |
| Q2 2023 | $217,552 | +59.0% | 17,321 | +40.4% | 0.00% | 0.0% |
| Q1 2023 | $136,795 | +2.1% | 12,335 | -1.3% | 0.00% | 0.0% |
| Q2 2022 | $134,000 | -69.7% | 12,500 | -73.0% | 0.00% | 0.0% |
| Q3 2021 | $442,000 | +46.4% | 46,259 | +47.8% | 0.00% | 0.0% |
| Q2 2021 | $302,000 | -94.2% | 31,299 | -94.1% | 0.00% | -96.8% |
| Q1 2021 | $5,252,000 | +404.0% | 531,611 | +371.3% | 0.03% | +14.8% |
| Q1 2020 | $1,042,000 | -9.7% | 112,795 | -21.6% | 0.03% | +170.0% |
| Q3 2019 | $1,154,000 | -43.9% | 143,942 | -12.6% | 0.01% | -50.0% |
| Q2 2019 | $2,056,000 | -46.4% | 164,735 | -41.6% | 0.02% | -51.2% |
| Q1 2019 | $3,837,000 | +1102.8% | 282,105 | +747.8% | 0.04% | +925.0% |
| Q4 2018 | $319,000 | -80.8% | 33,276 | -75.8% | 0.00% | -80.0% |
| Q3 2018 | $1,661,000 | +23.8% | 137,400 | +59.9% | 0.02% | +11.1% |
| Q2 2018 | $1,342,000 | -32.5% | 85,920 | -35.0% | 0.02% | -43.8% |
| Q1 2018 | $1,989,000 | +148.0% | 132,219 | +137.2% | 0.03% | +128.6% |
| Q4 2017 | $802,000 | +153.0% | 55,741 | +164.8% | 0.01% | +133.3% |
| Q3 2017 | $317,000 | -7.6% | 21,052 | -56.2% | 0.01% | -33.3% |
| Q1 2017 | $343,000 | +1.2% | 48,095 | -29.4% | 0.01% | -35.7% |
| Q4 2016 | $339,000 | +87.3% | 68,167 | +178.2% | 0.01% | +16.7% |
| Q3 2016 | $181,000 | -74.4% | 24,500 | -70.7% | 0.01% | -78.2% |
| Q1 2016 | $706,000 | +76.1% | 83,600 | +101.9% | 0.06% | +25.0% |
| Q4 2015 | $401,000 | -30.4% | 41,400 | +0.5% | 0.04% | -69.4% |
| Q3 2015 | $576,000 | +34.6% | 41,200 | -20.0% | 0.14% | -65.2% |
| Q4 2014 | $428,000 | – | 51,479 | – | 0.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |